TY  - GEN
AU  - Ilie,M I
AU  - Bence,C
AU  - Hofman,V
AU  - Long-Mira,E
AU  - Butori,C
AU  - Bouhlel,L
AU  - Lalvée,S
AU  - Mouroux,J
AU  - Poudenx,M
AU  - Otto,J
AU  - Marquette,C H
AU  - Hofman,P
TI  - Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies
SN  - 1569-8041
PY  - 2015///0824
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adenocarcinoma of Lung
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anaplastic Lymphoma Kinase
KW  - Crizotinib
KW  - Female
KW  - Fluorescent Antibody Technique
KW  - methods
KW  - Gene Dosage
KW  - genetics
KW  - Gene Rearrangement
KW  - Genetic Variation
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Protein Kinase Inhibitors
KW  - therapeutic use
KW  - Protein-Tyrosine Kinases
KW  - analysis
KW  - Proto-Oncogene Proteins
KW  - Proto-Oncogene Proteins c-met
KW  - Pyrazoles
KW  - Pyridines
KW  - Receptor Protein-Tyrosine Kinases
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1093/annonc/mdu484
ER  -